Johannes Gojo

pediatric neuro-oncologist, brain tumor research @MedUni_Wien

[Johannes Gojo @gojojohannes]

🎗️Thank you to more than 100 people who already helped us by filling out the survey! 🙏 We still need additional voices to help us and brain tumor patients by taking this short survey on liquid biopsies
Just fill it out online here until July 14th👇

https://t.co/O5Iqe109zR

[Johannes Gojo @gojojohannes]

💧Liquid biopsies are an emerging diagnostic tool likely to transform the way we treat children and adolescents suffering from brain tumors.
Participate in our survey among patients, families and health care providers and help us shape the future!
👇 https://t.co/O5Iqe109zR

[Johannes Gojo @gojojohannes]

@CancerRevengers Thank you - we are at 100 currently but are eager to hear MORE.
So please take the time to answer our survey until May 15th.

[Johannes Gojo @gojojohannes]

@MedUni_Wien @CERNfoundation @CCCVienna 🦋 We are thankful to participate in the Ependymoma Awareness Day 2024! Together we can drive the change for a better future for patients suffering from #epENDymoma

[Johannes Gojo @gojojohannes]

@CancerRevengers Thank you so much! We need the voices of patients and parents to improve treatment and care of children and adolescents with brain tumors 🎗️🧠

[Johannes Gojo @gojojohannes]

🎗️🧠 Danke an all die hervorragenden Vortragenden der ERSTEN Patient:innentagung für Hirntumore im Kindes- und Jugendalter 👶👧👦 gelebte interdisziplinäre Zusammenarbeit 👩‍⚕️👨‍⚕️@MedUni_Wien #kinderkrebs #cccvienna

[Johannes Gojo @gojojohannes]

🎗️🧠Danke an Gesundheits- und Sozialminister @johannes_rauch für die ergreifende und motivierende Eröffnungsrede zur ersten Patient:innentagung für Hirntumore des Kindes- und Jugendalters @MedUni_Wien Hirntumore sind die häufigste Krebserkrankung bei Kindern, 🙏 für den Support!

[Johannes Gojo @gojojohannes]

The countdown is running for day two of the 3rd Vienna Pediatric Brain Tumor Symposium @MedUni_Wien. We continue with excellent speakers and our first ever patient day. We are honored to welcome @johannes_rauch
Of course we continue with a lot of snow globes to be awarded 🧠🎡

[Johannes Gojo @gojojohannes]

We are thrilled to host fantastic speakers at our 3rd Vienna Pediatric Brain Tumor Symposium. Big thank you to @CarlKoschmann, Michal Zapotocky, Philipp Euskirchen, Eelco Hoving for joining our exciting meeting where we are “Translating Science to Patient Benefit” @MedUni_Wien

[Johannes Gojo @gojojohannes]

I am honored that our project was selected!!! Big thank you to everyone making this possible @NBTStweets @CERNfoundation
Within a great team together with @FilbinMariella @LoetschD @WalterBerger19 we seek to find better treatments for high-risk ependymoma #epENDymoma

[National Brain Tumor Society @NBTStweets]

NBTS is excited to announce that Johannes Gojo, MD, PhD, of Medical University of Vienna, is the recipient of the first-ever CERN PFA Ependymoma Translational Research Award.

Learn how this grant aims to jumpstart treatment development: https://t.co/ZIT5z5qw5A

[National Brain Tumor Society @NBTStweets]

NBTS is excited to announce that Johannes Gojo, MD, PhD, of Medical University of Vienna, is the recipient of the first-ever CERN PFA Ependymoma Translational Research Award.

Learn how this grant aims to jumpstart treatment development: https://t.co/ZIT5z5qw5A

[Johannes Gojo @gojojohannes]

@LisaGblr @oeaw Congratulations Lisa and proud to mentor you in this and many other projects! Well deserved 🏆
This project will explore new therapies for aggressive brain tumors in children 🎗️🧠

[Johannes Gojo @gojojohannes]

🧠🎗️Finally out - MEMMAT provides survival benefit for a subgroup of patients suffering from recurrent medulloblastoma. Fantastic international collaboration led by @andreaspeyrl @MedUni_Wien

Check it out here 👇
https://t.co/Fr0sksUybi

[NTRKers @NTRKers]

The @NTRKers virtual Patient Summit, on November 9th, is less than a month away. Check out an exclusive sneak peek of the agenda! We are thrilled to bring together patients, advocates, and healthcare providers from around the world as we discuss #TRK fusion cancers.

[Johannes Gojo @gojojohannes]

@React4Kids @KiTZ_HD @DKFZ @MedUni_Wien 🎗️Thank you @React4Kids for the invitation to your fantastic symposium. It is a pleasure to meet so many dedicated researchers and enjoy exciting science 🧬🔬💊

[Johannes Gojo @gojojohannes]

🏃‍♂️🏃‍♀️ I am proud of our amazing team of the 🎗️pediatric brain tumor center🧠 @MedUni_Wien and @CCCVienna running today's Cancer Research Run in Vienna! Making a difference for children with brain tumors in the clinics and labs - and on the running track💪

[Johannes Gojo @gojojohannes]

@MedUni_Wien @CCCVienna 🎗️It was a pleasure to host the final consortium meeting of ITCCP4 and the general assembly of the newly founded ITCCP4 gGmbH. A fantastic joint effort of even more fantastic people across academia and industry and a true milestone for children with cancer! 🎈 @ITCC_eu

[MedUni Wien @MedUni_Wien]

Das @CCCVienna beteiligt sich an der Gründung einer gemeinnützigen GmbH, die maßgeschneiderte Therapien für aggressive Formen von #Kinderkrebs entwickeln soll. Die europäische Spitze der Kinderonkologieforschung war aus diesem Anlass an der #MedUniWien! ⬇ https://t.co/hNtlrErsGV

[Comprehensive Cancer Center Vienna (CCC) @CCCVienna]

Europaweite präklinische Testplattform für seltene Tumoren bei Kindern etabliert und für die Zukunft gesichert. @MedUni_Wien #CCCVienna

➡️➡️https://t.co/JRHGcWJTbd

[Johannes Gojo @gojojohannes]

@ITCC_eu @StAnna_CCRI @MedUni_Wien We are honored to have hosted the 1st ITCC Scientific Days in Vienna! 🎡
Biggest thank you to all the amazing participants sharing exciting research🧬🔬 all aiming to understand and fight pediatric cancer🎗️